USANA Health Holds Annual Shareholders Meeting

USANA Health ( (USNA) ) has provided an update.

On May 19, 2025, USANA Health conducted its Annual Meeting of Shareholders, where approximately 92% of the company’s shares were represented. During the meeting, shareholders elected eight individuals to the Board of Directors, approved the 2025 Equity Incentive Plan, ratified KPMG LLP as the independent accounting firm for fiscal year 2025, and approved executive compensation on an advisory basis.

The most recent analyst rating on (USNA) stock is a Hold with a $65.00 price target. To see the full list of analyst forecasts on USANA Health stock, see the USNA Stock Forecast page.

Spark’s Take on USNA Stock

According to Spark, TipRanks’ AI Analyst, USNA is a Outperform.

USANA Health’s stock is supported by strong financial fundamentals, with robust gross margins and a solid balance sheet. The positive momentum in technical indicators and promising growth trajectory from recent earnings calls are significant positives. However, challenges like declining revenues, cautious consumer sentiment, and trade uncertainties slightly temper the overall outlook. The stock’s valuation is fair, but the lack of dividend yield may not appeal to all investors.

To see Spark’s full report on USNA stock, click here.

More about USANA Health

USANA Health is a company operating in the health and wellness industry, primarily focusing on nutritional supplements and personal care products.

Average Trading Volume: 242,981

Technical Sentiment Signal: Sell

Current Market Cap: $560M

See more data about USNA stock on TipRanks’ Stock Analysis page.